Q2 2026 13F · SEC CIK 2092021

Seven Fleet Capital Management LP

Hedge fundFiled 2026-08-17 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $605.9M
Reported positions: 96
Holdings vs S&P 500, 3 yrs: —
Assets under management: $434.6M

Seven Fleet Capital Management LP is a hedge fund that reported 96 positions worth $605.9M in its Q2 2026 13F, filed 2026-08-17. Its largest holdings were Cg Oncology Inc (CGON, 22.1%), Tango Therapeutics Inc (TNGX, 15.8%), Revolution Medicines Inc (RVMD, 7.5%).

Seven Fleet Capital Management LP holdings largest 50 of 96 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Seven Fleet Capital Management LP 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
CGONCg Oncology Inc	22.1%	1.6%	1,886,236	+2389.8%	$134.0M
TNGXTango Therapeutics Inc	15.8%	3.3%	3,228,144	+543.0%	$95.7M
RVMDRevolution Medicines Inc	7.5%	2.5%	242,029	+199.6%	$45.3M
PHVSPharvaris N V	4.4%	1.5%	774,501	+348.4%	$26.8M
LQDALiquidia Corporation	3.4%	2.2%	256,603	+36.6%	$20.5M
ELVNEnliven Therapeutics Inc	3.1%	2.0%	365,386	+122.8%	$18.5M
ABVXAbivax SA	2.4%	1.5%	111,334	+158.6%	$14.8M
AVTXAvalo Therapeutics Inc	2.4%	1.0%	770,765	+260.5%	$14.2M
MIRMMirum Pharmaceuticals Inc	2.1%	—	110,393	—	$12.9M
ASMBAssembly Biosciences Inc.	2.0%	0.5%	433,147	+671.5%	$11.9M
IPSCCentury Therapeutics Inc	1.8%	2.1%	4,347,826	+47.5%	$10.7M
CYTKCytokinetics	1.7%	1.3%	118,240	+93.0%	$10.1M
TSHATaysha Gene Therapies Inc	1.6%	0.9%	1,504,400	+140.4%	$9.9M
MANEVeradermics Inc	1.6%	—	80,000	—	$9.8M
AVBPArrivent Biopharma Inc	1.4%	—	246,606	—	$8.6M
TARSTarsus Pharmaceuticals Inc	1.3%	—	117,067	—	$7.9M
XNCRXencor Inc	1.3%	—	368,305	—	$7.8M
ROIVRoivant Sciences Ltd	1.3%	1.1%	220,126	+71.7%	$7.8M
GLTODamora Therapeutics Inc	1.2%	0.8%	284,430	+180.9%	$7.4M
AXSMAxsome Therapeutics, Inc.	1.2%	0.7%	28,826	+105.1%	$7.1M
24477V105Definium Therapeutics Inc	1.2%	0.6%	148,647	+48.8%	$7.0M
DNTHDianthus Therapeutics Inc	1.0%	1.4%	64,723	+19.3%	$6.3M
COGTCogent Biosciences Inc	0.9%	1.8%	147,510	-1.3%	$5.7M
ERASErasca, Inc.	0.9%	1.1%	308,007	+38.5%	$5.6M
PTGXProtagonist Therapeutics Inc	0.9%	—	45,400	—	$5.6M
NERVMinerva Neurosciences Inc	0.9%	0.5%	1,001,373	+303.0%	$5.6M
EDITEditas Medicine Inc	0.7%	—	1,330,500	—	$4.3M
CTMXCytomx Therapeutics Inc.	0.7%	0.5%	1,085,398	+192.2%	$4.1M
EPRXEupraxia Pharmaceuticals Inc	0.7%	1.0%	610,785	+40.9%	$4.0M
STROSutro Biopharma Inc	0.6%	—	159,118	—	$3.8M
RLAYRelay Therapeutics Inc	0.6%	0.8%	178,222	-30.9%	$3.3M
CLDXCelldex Therapeutics Inc New	0.5%	—	86,664	—	$3.2M
ASNDAscendis Pharma A/s	0.5%	—	11,869	—	$3.2M
SGMTSagimet Biosciences Inc	0.5%	—	403,545	—	$3.1M
ZLABZai Lab Ltd	0.5%	0.5%	136,016	+74.7%	$2.9M
SABSSab Biotherapeutics Inc	0.5%	—	736,077	—	$2.9M
MDGLMadrigal Pharmaceuticals Inc	0.4%	0.6%	4,973	+46.6%	$2.7M
PRAXPraxis Precision Medicines I	0.4%	—	7,540	—	$2.5M
RLMDRelmada Therapeutics Inc	0.4%	—	348,265	—	$2.4M
AGIOAgios Pharmaceuticals Inc	0.3%	2.2%	56,900	-72.8%	$2.1M
XENEXenon Pharmaceuticals Inc	0.3%	—	33,300	—	$2.1M
SVRASavara Inc	0.3%	0.5%	309,103	+4.5%	$1.9M
CCCCC4 Therapeutics Inc	0.3%	—	381,169	—	$1.8M
PCVXVaxcyte Inc	0.3%	2.0%	29,800	-72.5%	$1.8M
CELCCelcuity Inc	0.3%	—	16,252	—	$1.7M
SNDXSyndax Pharmaceuticals Inc	0.3%	—	77,930	—	$1.6M
ZNTLZentalis Pharmaceuticals Inc	0.2%	—	317,600	—	$1.5M
GPCRStructure Therapeutics F Unspo	0.2%	—	26,800	—	$1.4M
LONALeonabio Inc	0.2%	0.5%	154,153	-6.4%	$1.4M
IDYAIdeaya Biosciences Inc	0.2%	0.9%	37,865	-56.1%	$1.4M

What Seven Fleet Capital Management LP bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

CGON Cg Oncology Inc+2389.8% shares
ASMB Assembly Biosciences Inc.+671.5% shares
TNGX Tango Therapeutics Inc+543.0% shares
PHVS Pharvaris N V+348.4% shares
NERV Minerva Neurosciences Inc+303.0% shares
AVTX Avalo Therapeutics Inc+260.5% shares
RVMD Revolution Medicines Inc+199.6% shares
CTMX Cytomx Therapeutics Inc.+192.2% shares

Reduced

AGIO Agios Pharmaceuticals Inc-72.8% shares
PCVX Vaxcyte Inc-72.5% shares
IDYA Ideaya Biosciences Inc-56.1% shares
RLAY Relay Therapeutics Inc-30.9% shares
LONA Leonabio Inc-6.4% shares

Left the top 50

Cg Oncology Incwas 30.6%
TYRA Tyra Biosciences Incwas 2.4%
Tango Therapeutics Incwas 2.0%
Avalo Therapeutics Incwas 1.7%
Minerva Neurosciences Incwas 1.7%
Pharvaris N Vwas 1.3%
SLNO Soleno Therapeutics Incwas 1.2%
Enliven Therapeutics Incwas 1.2%

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: —
3 years: —
5 years: —

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$605.9M	96
Q1 2026	$318.3M	115
Q4 2025	$147.8M	85

Questions about Seven Fleet Capital Management LP's portfolio

What stocks does Seven Fleet Capital Management LP own?

Seven Fleet Capital Management LP's latest 13F, for Q2 2026 and filed Aug 17, 2026, lists 96 positions worth $605.9M. The largest are Cg Oncology Inc (CGON) at 22.1%, Tango Therapeutics Inc (TNGX) at 15.8%, Revolution Medicines Inc (RVMD) at 7.5%, Pharvaris N V (PHVS) at 4.4% and Liquidia Corporation (LQDA) at 3.4%.

What did Seven Fleet Capital Management LP buy last quarter?

In Q2 2026, Seven Fleet Capital Management LP added Cg Oncology Inc (CGON) (+2389.8% shares), Assembly Biosciences Inc. (ASMB) (+671.5% shares) and Tango Therapeutics Inc (TNGX) (+543.0% shares), compared with its Q1 2026 filing.

What did Seven Fleet Capital Management LP sell last quarter?

In Q2 2026, Seven Fleet Capital Management LP cut from its top 50 Cg Oncology Inc, cut from its top 50 Tyra Biosciences Inc (TYRA), cut from its top 50 Tango Therapeutics Inc, cut from its top 50 Avalo Therapeutics Inc, cut from its top 50 Minerva Neurosciences Inc, Agios Pharmaceuticals Inc (AGIO) (-72.8% shares), Vaxcyte Inc (PCVX) (-72.5% shares) and Ideaya Biosciences Inc (IDYA) (-56.1% shares), compared with its Q1 2026 filing.

When is Seven Fleet Capital Management LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Seven Fleet Capital Management LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Seven Fleet Capital Management LP manage?

Seven Fleet Capital Management LP reported $434.6M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $605.9M.